| Working Paper |
File Downloads |
Abstract Views |
| Last month |
3 months |
12 months |
Total |
Last month |
3 months |
12 months |
Total |
| A Computational View of Market Efficiency |
0 |
0 |
0 |
109 |
2 |
4 |
11 |
437 |
| A Cost/Benefit Analysis of Clinical Trial Designs for COVID-19 Vaccine Candidates |
0 |
0 |
0 |
46 |
0 |
3 |
12 |
167 |
| A Dynamic Model of Optimal Investment and Financial Policies with Costs of Adjustment and Leverage |
0 |
0 |
0 |
1 |
2 |
7 |
18 |
207 |
| A Nonparametric Approach to Pricing and Hedging Derivative Securities Via Learning Networks |
0 |
2 |
5 |
237 |
2 |
10 |
53 |
752 |
| A Residuals-Based Wald Test for the Linear Simultaneous Equation |
0 |
0 |
0 |
0 |
0 |
2 |
6 |
292 |
| A Residuals-Based Wald Test for the Linear Simultaneous Equation |
0 |
0 |
0 |
0 |
1 |
2 |
7 |
158 |
| A Simple Specification Test of the Random Walk Hypothesis |
0 |
0 |
0 |
2 |
0 |
3 |
14 |
1,024 |
| A Survey of Systemic Risk Analytics |
1 |
6 |
8 |
116 |
2 |
21 |
50 |
517 |
| Accelerating Vaccine Innovation for Emerging Infectious Diseases via Parallel Discovery |
0 |
0 |
0 |
3 |
0 |
5 |
9 |
22 |
| An Econometric Analysis of Nonsynchronous Trading |
2 |
4 |
4 |
362 |
2 |
8 |
20 |
860 |
| An Econometric Analysis of Nonsyschronous-Trading |
0 |
0 |
0 |
0 |
0 |
1 |
5 |
234 |
| An Econometric Model of Serial Correlation and Illiquidity In Hedge Fund Returns |
1 |
2 |
5 |
178 |
2 |
12 |
35 |
662 |
| An Econometric Model of Serial Correlation and Illiquidity in Hedge Fund Returns |
0 |
0 |
2 |
532 |
2 |
8 |
33 |
1,568 |
| An Ordered Probit Analysis of Transaction Stock Prices |
0 |
0 |
1 |
540 |
0 |
2 |
16 |
1,783 |
| An Ordered Probit Analysis of Transaction Stock Prices |
0 |
0 |
0 |
0 |
0 |
1 |
8 |
910 |
| An Ordered Probit Analysis of Transaction Stock Prices (Reprint 029) |
0 |
0 |
0 |
0 |
1 |
1 |
6 |
569 |
| An ordered probit analysis of transaction stock prices |
0 |
0 |
0 |
142 |
0 |
4 |
13 |
420 |
| Asset Prices and Trading Volume Under Fixed Transactions Costs |
0 |
0 |
0 |
145 |
1 |
7 |
21 |
725 |
| Asset Prices and Trading Volume Under Fixed Transactions Costs |
0 |
0 |
0 |
70 |
0 |
0 |
4 |
310 |
| Asset Prices and Trading Volume Under Fixed Transactions Costs |
1 |
1 |
1 |
3 |
1 |
5 |
14 |
19 |
| Bayesian Adaptive Clinical Trials for Anti‐Infective Therapeutics during Epidemic Outbreaks |
0 |
0 |
0 |
5 |
1 |
5 |
18 |
62 |
| Competition and R&D Financing Decisions: Theory and Evidence from the Biopharmaceutical Industry |
0 |
0 |
1 |
73 |
1 |
6 |
17 |
248 |
| Data Snooping Biases in Tests of Financial Asset Pricing Models (Reprint 002) |
0 |
0 |
0 |
1 |
0 |
0 |
4 |
345 |
| Data-Snooping Biases in Tests of Financial Asset Pricing Models |
0 |
0 |
0 |
145 |
0 |
4 |
18 |
537 |
| Data-snooping biases in tests of financial asset pricing models |
1 |
2 |
2 |
88 |
3 |
7 |
21 |
329 |
| Econometric Measures of Connectedness and Systemic Risk in the Finance and Insurance Sectors |
0 |
2 |
2 |
382 |
1 |
5 |
22 |
951 |
| Econometric Measures of Systemic Risk in the Finance and Insurance Sectors |
0 |
1 |
3 |
389 |
2 |
6 |
29 |
1,094 |
| Econometric Models of Limit-Order Executions |
0 |
1 |
1 |
399 |
0 |
4 |
14 |
1,270 |
| Econometric Models of Limit-Order Executions |
0 |
2 |
3 |
168 |
2 |
5 |
12 |
757 |
| Estimating Probabilities of Success of Vaccine and Other Anti-Infective Therapeutic Development Programs |
0 |
0 |
1 |
12 |
0 |
3 |
13 |
66 |
| Estimating the Financial Impact of Gene Therapy in the U.S |
1 |
1 |
1 |
16 |
2 |
4 |
27 |
81 |
| Fear and Greed in Financial Markets: A Clinical Study of Day-Traders |
0 |
0 |
2 |
311 |
5 |
36 |
88 |
1,495 |
| Financial Intermediation and the Funding of Biomedical Innovation: A Review |
0 |
1 |
1 |
16 |
1 |
4 |
10 |
43 |
| Financing Vaccines for Global Health Security |
0 |
0 |
0 |
25 |
1 |
6 |
14 |
75 |
| Foundations of Technical Analysis: Computational Algorithms, Statistical Inference, and Empirical Implementation |
1 |
1 |
1 |
1,320 |
4 |
25 |
59 |
2,428 |
| Foundations of Technical Analysis: Computational Algorithms, Statistical Inference, and Empirical Implementation |
3 |
7 |
18 |
1,873 |
26 |
65 |
164 |
4,280 |
| Frontiers of Finance: Evolution and Efficient Markets |
0 |
0 |
0 |
521 |
1 |
3 |
21 |
1,686 |
| Games of Survival in the Newspaper Industry |
0 |
0 |
0 |
0 |
1 |
1 |
5 |
241 |
| Global realignment in financial market dynamics: Evidence from ETF networks |
0 |
1 |
2 |
56 |
1 |
6 |
19 |
108 |
| Hedge Funds: A Dynamic Industry In Transition |
0 |
1 |
2 |
87 |
1 |
9 |
40 |
300 |
| Hedge fund holdings and stock market efficiency |
0 |
1 |
2 |
70 |
1 |
6 |
18 |
282 |
| Implementing Option Pricing Models When Asset Returns Are Predictable |
0 |
0 |
0 |
459 |
0 |
0 |
13 |
1,568 |
| Implementing option pricing models when asset returns are predictable |
0 |
0 |
0 |
80 |
1 |
2 |
10 |
261 |
| Impossible Frontiers |
0 |
0 |
0 |
65 |
0 |
2 |
16 |
318 |
| Information Dissemination and Aggregation in Asset Markets with Simple Intelligent Traders |
1 |
1 |
1 |
240 |
3 |
8 |
13 |
900 |
| Is It Real, or Is It Randomized?: A Financial Turing Test |
1 |
1 |
1 |
66 |
1 |
1 |
8 |
168 |
| Is the FDA Too Conservative or Too Aggressive?: A Bayesian Decision Analysis of Clinical Trial Design |
0 |
0 |
0 |
14 |
0 |
12 |
19 |
114 |
| Logit Versus Discriminant Analysis: A Specification Test |
0 |
0 |
0 |
1 |
1 |
3 |
11 |
520 |
| Long-term Memory in Stock Market Prices |
0 |
0 |
1 |
287 |
1 |
15 |
35 |
990 |
| Long-term memory in stock market prices |
1 |
1 |
3 |
170 |
3 |
12 |
35 |
598 |
| Maximizing Predictability in the Stock and Bond Markets |
0 |
0 |
1 |
749 |
1 |
4 |
12 |
2,083 |
| Maximizing predictability in the stock and bond markets |
0 |
0 |
1 |
98 |
1 |
2 |
14 |
385 |
| Maximum Likelihood Estimation of Generalized Ito Processes with Discretely Sampled Data |
0 |
0 |
1 |
408 |
1 |
4 |
18 |
1,071 |
| Maximum Likelihood Estimation of Generalized Ito Processes with Discretely Sampled Data |
0 |
0 |
0 |
0 |
0 |
1 |
10 |
276 |
| Models of the term structure of interest rates |
0 |
0 |
0 |
0 |
0 |
1 |
3 |
464 |
| Moore's Law vs. Murphy's Law in the financial system: who's winning? |
0 |
0 |
1 |
46 |
3 |
7 |
29 |
113 |
| Nonparametric Estimation of State-Price Densities Implicit in Financial Asset Prices |
0 |
0 |
0 |
1 |
1 |
5 |
8 |
491 |
| Nonparametric Estimation of State-Price Densities Implicit in Financial Asset Prices |
0 |
0 |
0 |
576 |
2 |
9 |
25 |
2,044 |
| Nonparametric Risk Management and Implied Risk Aversion |
0 |
0 |
1 |
499 |
1 |
6 |
29 |
1,332 |
| Optimal Financing for R&D-Intensive Firms |
0 |
0 |
2 |
50 |
2 |
9 |
19 |
129 |
| Paying off the Competition: Contracting, Market Power, and Innovation Incentives |
0 |
0 |
0 |
54 |
3 |
5 |
26 |
155 |
| Pricing and Hedging Derivative Securities in Incomplete Markets: An E-Aritrage Model |
0 |
0 |
0 |
986 |
0 |
6 |
11 |
3,617 |
| Pricing and hedging derivative securities in incomplete markets: an e-arbitrage approach |
0 |
0 |
0 |
76 |
0 |
0 |
8 |
298 |
| Privacy-Preserving Methods for Sharing Financial Risk Exposures |
0 |
0 |
0 |
15 |
1 |
2 |
6 |
83 |
| Risk and Risk Management in the Credit Card Industry |
0 |
0 |
1 |
91 |
2 |
6 |
22 |
375 |
| Sharing R&D Risk in Healthcare via FDA Hedges |
0 |
0 |
2 |
30 |
0 |
5 |
20 |
113 |
| Statistical Tests of Contingent Claims Asset-Pricing Models: A New Methodology (Revised: 10-85) |
0 |
0 |
0 |
0 |
1 |
6 |
13 |
163 |
| Statistical Tests of Contingent Claims Asset-Pricing Models: A New Methodology (Revision of 19-84) |
0 |
0 |
0 |
0 |
0 |
0 |
6 |
189 |
| Stock Market Prices Do Not Follow Random Walks: Evidence From a Simple Specification Test |
0 |
0 |
18 |
1,001 |
4 |
21 |
90 |
3,307 |
| Stock Market Prices Do Not Follow Random Walks: Evidence from a Simple Specification Test (Revised: 29-87) |
0 |
0 |
0 |
0 |
1 |
12 |
30 |
258 |
| Stock Market Prices Do Not Follow Random Walks: Evidence from a Simple Specification Test (Revised: 29-87) |
0 |
0 |
0 |
0 |
1 |
4 |
11 |
473 |
| Stock Market Prices Do Not Follow Random Walks: Evidence from a Simple Specification Test (Revision of 5-87) |
0 |
0 |
0 |
0 |
0 |
4 |
16 |
366 |
| Systemic Risk and Hedge Funds |
0 |
1 |
1 |
824 |
0 |
8 |
32 |
2,256 |
| Systemic Risk and the Refinancing Ratchet Effect |
0 |
0 |
0 |
162 |
0 |
3 |
9 |
571 |
| Systemic Risk and the Refinancing Ratchet Effect |
0 |
0 |
0 |
125 |
0 |
1 |
14 |
564 |
| The Gordon Gekko Effect: The Role of Culture in the Financial Industry |
0 |
0 |
0 |
94 |
0 |
5 |
18 |
310 |
| The Psychophysiology of Real-Time Financial Risk Processing |
0 |
0 |
2 |
168 |
2 |
22 |
48 |
690 |
| The Risk, Reward, and Asset Allocation of Nonprofit Endowment Funds |
0 |
0 |
15 |
15 |
5 |
9 |
56 |
56 |
| The Size and Power of the Variance Ratio Test in Finite Samples: A Monte Carlo Investigation |
0 |
0 |
2 |
474 |
1 |
7 |
31 |
1,603 |
| The Size and Power of the Variance Ratio Test in Finite Samples: A Monte Carlo Investigation |
0 |
0 |
0 |
0 |
1 |
5 |
19 |
1,018 |
| The Sources and Nature of Long-Term Memory in the Business Cycle |
0 |
0 |
0 |
0 |
1 |
3 |
8 |
516 |
| The Sources and Nature of Long-Term Memory in the Business Cycle |
0 |
0 |
0 |
1 |
0 |
2 |
12 |
228 |
| The Sources and Nature of Long-term Memory in the Business Cycle |
0 |
0 |
1 |
91 |
0 |
1 |
13 |
476 |
| The sources and nature of long-term memory in the business cycle |
0 |
0 |
0 |
40 |
1 |
4 |
13 |
311 |
| Trading Volume: Definitions, Data Analysis, and Implications of Portfolio Theory |
2 |
2 |
3 |
668 |
4 |
5 |
15 |
2,301 |
| Trading Volume: Implications of An Intertemporal Capital Asset Pricing Model |
0 |
0 |
0 |
233 |
0 |
6 |
21 |
791 |
| WARNING: Physics Envy May Be Hazardous To Your Wealth! |
0 |
1 |
4 |
431 |
1 |
15 |
38 |
1,327 |
| What Happened To The Quants In August 2007?: Evidence from Factors and Transactions Data |
0 |
1 |
1 |
261 |
3 |
28 |
50 |
931 |
| When Do Stop-Loss Rules Stop Losses? |
2 |
3 |
7 |
165 |
10 |
51 |
127 |
666 |
| When are Contrarian Profits Due to Stock Market Overreaction (Reprint 001) |
0 |
0 |
0 |
4 |
0 |
3 |
13 |
504 |
| When are Contrarian Profits Due to Stock Market Overreaction (Reprint 001) |
0 |
0 |
0 |
0 |
1 |
3 |
7 |
279 |
| When are Contrarian Profits Due to Stock Market Overreaction? |
0 |
1 |
2 |
410 |
2 |
15 |
40 |
1,197 |
| When are contrarian profits due to stock market overreaction? |
0 |
0 |
0 |
147 |
0 |
11 |
22 |
462 |
| Total Working Papers |
18 |
48 |
140 |
18,818 |
139 |
697 |
2,180 |
68,593 |
| Journal Article |
File Downloads |
Abstract Views |
| Last month |
3 months |
12 months |
Total |
Last month |
3 months |
12 months |
Total |
| A Nonparametric Approach to Pricing and Hedging Derivative Securities via Learning Networks |
0 |
0 |
2 |
120 |
0 |
7 |
47 |
545 |
| A Survey of Systemic Risk Analytics |
0 |
4 |
10 |
461 |
2 |
19 |
68 |
1,522 |
| A computational view of market efficiency |
0 |
0 |
1 |
21 |
1 |
2 |
10 |
170 |
| A large-sample chow test for the linear simultaneous equation |
0 |
0 |
0 |
117 |
0 |
1 |
4 |
362 |
| An Evolutionary Model of Bounded Rationality and Intelligence |
0 |
0 |
0 |
0 |
0 |
4 |
11 |
17 |
| An econometric analysis of nonsynchronous trading |
1 |
2 |
5 |
457 |
4 |
9 |
30 |
1,144 |
| An econometric model of serial correlation and illiquidity in hedge fund returns |
2 |
4 |
11 |
225 |
6 |
30 |
86 |
1,056 |
| An ordered probit analysis of transaction stock prices |
0 |
0 |
2 |
569 |
0 |
6 |
45 |
1,472 |
| Asset Prices and Trading Volume under Fixed Transactions Costs |
1 |
1 |
1 |
27 |
3 |
7 |
21 |
450 |
| Asset allocation and derivatives |
0 |
0 |
0 |
20 |
0 |
3 |
6 |
132 |
| Can Financial Economics Cure Cancer? |
0 |
0 |
0 |
1 |
0 |
3 |
7 |
28 |
| Can Financial Engineering Cure Cancer? |
0 |
0 |
1 |
58 |
1 |
3 |
14 |
282 |
| Can hedge funds time market liquidity? |
0 |
0 |
0 |
42 |
1 |
7 |
17 |
330 |
| Consumer credit-risk models via machine-learning algorithms |
2 |
6 |
59 |
849 |
20 |
48 |
319 |
2,755 |
| Data-Snooping Biases in Tests of Financial Asset Pricing Models |
0 |
0 |
0 |
618 |
2 |
2 |
24 |
1,825 |
| Econometric measures of connectedness and systemic risk in the finance and insurance sectors |
8 |
14 |
41 |
698 |
32 |
73 |
227 |
2,257 |
| Econometric models of limit-order executions |
0 |
0 |
4 |
202 |
0 |
1 |
20 |
588 |
| Estimating the NIH Efficient Frontier |
0 |
0 |
0 |
0 |
0 |
2 |
9 |
12 |
| Fear and Greed in Financial Markets: A Clinical Study of Day-Traders |
0 |
0 |
2 |
150 |
3 |
17 |
50 |
747 |
| Foundations of Technical Analysis: Computational Algorithms, Statistical Inference, and Empirical Implementation |
1 |
1 |
6 |
31 |
8 |
26 |
72 |
179 |
| Hamilton’s rule in economic decision-making |
0 |
0 |
0 |
11 |
0 |
4 |
15 |
38 |
| Hedge Fund Holdings and Stock Market Efficiency |
1 |
1 |
1 |
14 |
1 |
9 |
32 |
100 |
| Hedge Funds: A Dynamic Industry in Transition |
0 |
1 |
4 |
25 |
3 |
7 |
24 |
150 |
| Hedging Derivative Securities and Incomplete Markets: An (epsilon)-Arbitrage Approach |
0 |
1 |
3 |
15 |
0 |
1 |
12 |
65 |
| Identifying and Mitigating Potential Biases in Predicting Drug Approvals |
0 |
0 |
0 |
5 |
0 |
1 |
3 |
16 |
| Illiquidity Premia in Asset Returns: An Empirical Analysis of Hedge Funds, Mutual Funds, and US Equity Portfolios |
0 |
0 |
1 |
25 |
4 |
7 |
37 |
219 |
| Implementing Option Pricing Models When Asset Returns Are Predictable |
0 |
0 |
0 |
148 |
3 |
11 |
33 |
529 |
| Impossible Frontiers |
0 |
0 |
0 |
15 |
0 |
4 |
15 |
275 |
| Innovation at MIT |
0 |
0 |
0 |
3 |
0 |
2 |
9 |
63 |
| Introduction to Volume 5 of the Annual Review of Financial Economics |
0 |
0 |
0 |
18 |
0 |
3 |
11 |
110 |
| Is the FDA too conservative or too aggressive?: A Bayesian decision analysis of clinical trial design |
0 |
2 |
4 |
29 |
3 |
10 |
32 |
163 |
| Logit versus discriminant analysis: A specification test and application to corporate bankruptcies |
0 |
0 |
2 |
405 |
0 |
2 |
10 |
774 |
| Long-Term Memory in Stock Market Prices |
0 |
0 |
2 |
1,287 |
7 |
19 |
71 |
4,700 |
| MAXIMIZING PREDICTABILITY IN THE STOCK AND BOND MARKETS |
0 |
0 |
2 |
72 |
1 |
3 |
19 |
373 |
| Macroeconomic Models for Monetary Policy: A Critical Review from a Finance Perspective |
0 |
0 |
0 |
23 |
4 |
7 |
14 |
84 |
| Maximum Likelihood Estimation of Generalized Itô Processes with Discretely Sampled Data |
0 |
0 |
1 |
44 |
1 |
6 |
36 |
179 |
| Moore's Law versus Murphy's Law: Algorithmic Trading and Its Discontents |
0 |
0 |
1 |
62 |
0 |
6 |
21 |
258 |
| Nonparametric risk management and implied risk aversion |
1 |
1 |
3 |
525 |
2 |
9 |
34 |
1,326 |
| Optimal control of execution costs |
2 |
4 |
8 |
863 |
6 |
15 |
56 |
1,885 |
| Preface to the Annual Review of Financial Economics |
0 |
0 |
0 |
53 |
0 |
1 |
8 |
238 |
| Privacy-Preserving Methods for Sharing Financial Risk Exposures |
0 |
0 |
0 |
23 |
0 |
0 |
9 |
189 |
| Reading about the Financial Crisis: A Twenty-One-Book Review |
0 |
1 |
2 |
443 |
1 |
6 |
27 |
1,335 |
| Regulatory reform in the wake of the financial crisis of 2007‐2008 |
0 |
0 |
0 |
50 |
1 |
8 |
29 |
368 |
| Reply to “(Im)Possible Frontiers: A Comment†|
0 |
0 |
0 |
16 |
0 |
2 |
3 |
71 |
| Return Smoothing, Liquidity Costs, and Investor Flows: Evidence from a Separate Account Platform |
0 |
0 |
1 |
4 |
1 |
3 |
15 |
28 |
| Risk and risk management in the credit card industry |
0 |
1 |
1 |
40 |
1 |
11 |
27 |
251 |
| Robert C. Merton: The First Financial Engineer |
0 |
0 |
0 |
13 |
0 |
4 |
11 |
50 |
| Robust ranking and portfolio optimization |
0 |
0 |
3 |
43 |
0 |
4 |
18 |
139 |
| Semi-parametric upper bounds for option prices and expected payoffs |
0 |
1 |
1 |
211 |
0 |
3 |
8 |
380 |
| Spectral factor models |
1 |
3 |
6 |
39 |
3 |
13 |
41 |
149 |
| Statistical tests of contingent-claims asset-pricing models: A new methodology |
0 |
0 |
0 |
78 |
0 |
1 |
7 |
220 |
| Stock Market Prices do not Follow Random Walks: Evidence from a Simple Specification Test |
2 |
3 |
7 |
1,526 |
9 |
19 |
43 |
3,773 |
| Systemic risk and the refinancing ratchet effect |
0 |
0 |
1 |
88 |
0 |
3 |
18 |
587 |
| THE ECONOMETRICS OF FINANCIAL MARKETS |
19 |
57 |
124 |
707 |
38 |
129 |
301 |
1,907 |
| The Derivatives Sourcebook |
0 |
0 |
2 |
64 |
13 |
31 |
83 |
470 |
| The Gordon Gekko effect: the role of culture in the financial industry |
0 |
0 |
2 |
61 |
1 |
4 |
28 |
435 |
| The Origin of Behavior |
0 |
1 |
3 |
15 |
1 |
4 |
24 |
73 |
| The Visible Hand |
0 |
0 |
0 |
6 |
1 |
6 |
11 |
42 |
| The growth of relative wealth and the Kelly criterion |
0 |
0 |
2 |
19 |
2 |
5 |
31 |
117 |
| The origin of cooperation |
0 |
0 |
0 |
2 |
0 |
3 |
7 |
25 |
| The size and power of the variance ratio test in finite samples: A Monte Carlo investigation |
0 |
0 |
0 |
453 |
0 |
4 |
29 |
1,088 |
| The sources and nature of long-term memory in aggregate output |
0 |
0 |
0 |
80 |
0 |
2 |
15 |
451 |
| To maximize or randomize? An experimental study of probability matching in financial decision making |
0 |
0 |
0 |
2 |
0 |
6 |
10 |
22 |
| Trading Volume: Definitions, Data Analysis, and Implications of Portfolio Theory |
0 |
0 |
0 |
1 |
3 |
8 |
19 |
983 |
| Trading Volume: Implications of an Intertemporal Capital Asset Pricing Model |
0 |
0 |
0 |
117 |
0 |
8 |
21 |
493 |
| Variety Is the Spice of Life: Irrational Behavior as Adaptation to Stochastic Environments |
0 |
0 |
1 |
13 |
1 |
6 |
20 |
135 |
| What happened to the quants in August 2007? Evidence from factors and transactions data |
1 |
2 |
9 |
391 |
5 |
20 |
67 |
1,650 |
| When Are Contrarian Profits Due to Stock Market Overreaction? |
0 |
2 |
4 |
987 |
4 |
26 |
68 |
2,840 |
| When do stop-loss rules stop losses? |
2 |
3 |
8 |
166 |
16 |
52 |
97 |
679 |
| When is time continuous? |
0 |
0 |
1 |
111 |
2 |
5 |
16 |
488 |
| Total Journal Articles |
44 |
116 |
355 |
14,077 |
221 |
793 |
2,682 |
46,856 |